BMRN — Biomarin Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Biomarin Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,065	1,014	1,292	1,074	1,138
Net Total Accounts Receivable
Net Total Receivables	448	373	461	634	661
Total Inventory
Total Other Current Assets
Total Current Assets	2,342	2,274	2,751	2,956	3,232
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,090	1,082	1,114	1,112	1,077
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5,848	6,003	6,375	6,842	6,989
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	493	540	589	1,177	607
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,742	1,733	1,772	1,890	1,331
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	4,106	4,271	4,603	4,952	5,658
Total Liabilities & Shareholders' Equity	5,848	6,003	6,375	6,842	6,989
Total Common Shares Outstanding